Molecular Insight into Recognition of the CGRPR Complex by Migraine Prevention Therapy Aimovig (Erenumab)

Fernando Garcés(Amgen (United States)), Zhulun Wang(Amgen (United States)), Li Zhang(Jinan University), Christopher Mohr(Amgen (United States)), Chadwick King(Amgen (Canada)), Ching-Shin Huang(Pfizer (United States)), Cen Xu(Amgen (United States)), Qing Chen(Queensland University of Technology)
Cell Reports
February 1, 2020
Cited by 52


Related Papers